USPTO serial 79034206
QUANTIFAST
Reviewed by CopyMark Law Group
Reg. 3524308Status 706Registered
- Filing date
- Status date
- Registration date
- Oct 28, 2008
- Examiner
- SOBRAL, CHRISTINA
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with QUANTIFAST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Victoria Friedman
Victoria Friedman Dennemeyer & Associates, LLC.2 North Riverside Plaza, Suite 1500Chicago, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical reagents and solvents for scientific, and/or medical research use for [ sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, ] duplicating and/or analytic methods for biopolymers, in particular nucleic acids, [ proteins, macromolecules ] and biologically active substances, in particular reagents and solvents for nucleic acid amplification, in particular by polymerase chain reaction (PCR); kits comprising chemicals for [ sample preparation, modification and manipulation of cells and ] for marking, [ separating, isolating, purifying, ] duplicating and/or for the analysis of biopolymers, in particular nucleic acids, [ proteins, macromolecules and biologically active substances, in particular nucleic acids ] of biological or biochemical sample material, in particular comprising chemicals for reagents and solvents for nucleic acid amplification, in particular by polymerase chain reaction (PCR) | ACTIVE | — |
| 005 | Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics, in particular for [ sample preparation, modification and manipulation of cells and for ] marking, [ separating, isolating, purifying, ] duplicating and/or for the analysis of biopolymers, in particular nucleic acids, [ proteins, macromolecules ] and biologically active substances, in particular preparations for medical and veterinary purposes for reagents and solvents for nucleic acid amplification, in particular by polymerase chain reaction (PCR); chemical, biochemical and biotechnological preparations, in particular reagents and solvents for [ sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and/or ] analysis methods for biopolymers, in particular nucleic acids, [ proteins, macromolecules ] and biologically active substances for diagnostic medical use, and clinical use in particular reagents and solvents for nucleic acid amplification, in particular by polymerase chain reaction (PCR); kits containing preparations for medical and veterinary diagnostic purposes, in particular for [ sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, ] duplicating and/or for the analysis of biopolymers, in particular nucleic acids from biological or biochemical sample material, in particular for nucleic acid amplification, in particular by polymerase chain reaction (PCR) | ACTIVE | — |
| 009 | [ Scientific apparatuses, instruments and equipment and laboratory instruments and measuring apparatuses and instruments in particular for research, medical, diagnostic and analysis purposes, namely, disposable laboratory articles, namely, vessels plastic vessels, sample storage vessels, reaction and collection vessels and plates, multi-well plates, tips, including filter tips and dispenser tips, pipette tips and tip boxes, tubes, microtubes and tubes for PCR and micro centrifuges and micro-injection, capillaries, curvettes, spin columns, cartridges and columns filed with chromatographic material for the separation, purification, and isolation of biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material, in particular nucleic acids from biological or biochemical sample material, in particular for nucleic acid amplification, in particular by polymerase chain reaction (PCR); racks and holders for samples storage vessels, tubes, syringes and tips; magnetic beads, membranes and silica material for nucleic acid isolation and purification, sample presentation devices, mircroarrays, chips, MALDI-MS presentation devices; laboratory robots, robotic workstations and systems and laboratory incubators for diagnostic, clinical and research applications for the preparation, modification, isolation, crystallization, handling, amplification and manipulation of samples and for the marking, separation, isolation, purification, reproduction and analysis of biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material, in particular nucleic acids from biological or biochemical sample material, in particular for nucleic acid amplification, in particular by polymerase chain reaction (PCR); laboratory apparatuses and equipment for dosage, dispensing, transferring, temperature equalizing, agitating, mixing, diluting, concentrating and separating of liquids; MALDI- apparatuses, workstations for reading and handling multi-well plates for the analysis of biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material in particular nucleic acids from biological or biochemical sample material, in particular for nucleic acid amplification, in particular by polymerase chain reaction (PCR); cyclers, thermocyclers, lysis apparatuses, disrupters, physico-chemical, bio-chemical, optical and electronic analysis apparatus and equipment, in particular photometers, spectrophotometers, optical scanners for detection of fluorescence and colorimetric signals; apparatuses for processing cells or liquids containing cells in particular electroporators, electrofusion apparatuses, micro injectors and micro manipulators; vacuum chambers for chromatography, purification, separation and characterization of natural and synthetic biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material; centrifuges; vacuum systems for laboratory use, vacuum concentrators; centrifugal concentrators; rotors for laboratory centrifuges and vacuum concentrators, mixers; mechanical, electronical and automatical pipettes and dispensers for dispensing liquid for laboratory research and analysis purposes ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QIAGEN GmbH
- Other trademarks owned by QIAGEN GmbH
- Other trademarks owned by QIAGEN GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named QUANTIFAST
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 20, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 17, 2019 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jun 24, 2019 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 24, 2018 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Oct 24, 2018 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Oct 16, 2018 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 28, 2017 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 1, 2016 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Sep 11, 2015 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 18, 2015 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 18, 2015 | INPC | INVALIDATION PROCESSED | — |
| Jun 30, 2015 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 30, 2014 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Oct 30, 2014 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Oct 30, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 22, 2014 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Dec 13, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 5, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 5, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 5, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 28, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 28, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 12, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 7, 2008 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 24, 2008 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 24, 2008 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 23, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 7, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 3, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 3, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 3, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 3, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 3, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 20, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 20, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 7, 2008 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 7, 2008 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 7, 2008 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 30, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 23, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 27, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 27, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 27, 2007 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 20, 2007 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 5, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 5, 2007 | ALIE | ASSIGNED TO LIE | — |
| Sep 6, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 29, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 29, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 29, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2007 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 8, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 8, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 6, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 5, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2007 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Mar 1, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 28, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 23, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Feb 22, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |